The Food and Drug Administration has reportedly granted full approval to the Pfizer-BioNTech coronavirus vaccine.

The vaccine has been approved for people 16 years of age and older, which makes the vaccine the first one to go past the emergency use status granted to Moderna and previously—Johnson & Johnson. FDA commissioner Janet Woodcock spoke on the full approval, saying, “The public can be very confident that this vaccine meets the high standards for safety, effectiveness and manufacturing quality the FDA requires of an approved product.

The CEO of Pfizer—Albert Bourla, said he hopes the move by the FDA “will help increase confidence in our vaccine, as vaccination remains the best tool we have to help protect lives.” Reports noted the shot will now go by the name Comirnaty in the United States. As of now, over half of the United States population has been fully vaccinated with one of the three vaccine options from Johnson & Johnson, Moderna, or Pfizer.